Equity
€135,721 ▼ 20.4%
Care4Excellence paid out €120,233 in dividends. That is 141% of the 2025 profit.
Care4Excellence
Lifetime
17 annual accounts with figures on one time axispeak €131,173 (2025)
€131,173▲ 102%
lowest -€14,608 (2013)
€85,494▲ 111%
peak €207,531 (2022)
€135,721▼ 20.4%
€171,529▲ 83.7%
Board1 name since 2018
1 directorHUTS Colette
Owners
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Gross margin from €64,938 to €131,173Result from €40,467 to €85,494Dividend €120,233Equity from €170,460 to €135,721Debts from €93,367 to €171,529
Key points
from the 2025 annual accountsTurnover
≈ €330,000 estimated
The micro format states no turnover.
Debts
€171,529 ▲ 83.7%
Debts rose by €78,162 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
1.70 was 2.65 in 2024
Short-term debts rose from €91,633 to €171,529.
Filings
17 annual accounts since 2009
The last five annual accounts were filed 9 to 32 days before the end of the period.
Position in the sector
€85,494
Higher net result than 89% of companies in pharmaceuticals. Sector median €8,736 · 75 companies.
Checked score
89
Excellent
Financially stronger than 50% of micro companies in pharmaceuticals (NACE 21)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 152 companies (NACE 21, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.2%▲ +0.1 percentage points vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.2%▼ -0.1 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 1.70, cash €8,296
lowers risk
Founded in 2007
Size: total assets €307,250
Figures for financial year 2025 (filed on 22-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 55% of them on solvency, 24% on liquidity, 94% on profitability and 28% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as Care4Excellence has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of Care4Excellence itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for Care4Excellence. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.7 (2.65 in 2024), above the usual 1.5. Short-term debt is 55.8% and cash 2.7% of total assets. However, 55.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
9 days early
2024
15 days early
2023
19 days early
2022
32 days early
2021
20 days early
2020
22 days early
2019
17 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0886785777
Resignation: HUTS Colette (director)
Reappointment: HUTS Colette (director) · Director discharge: HUTS Colette · General meeting of 24-09-2020 · Gazette deed
Incorporation
published on 06-02-2007 · Gazette deed
First establishment
Akkerplein 7, Overijse
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Care4Excellence Overijse | €307,250 | €131,173 | 44.2% | - |
| DENTALEX Schilde | €266,453 | €140,550 | 15.3% | - |
| Brussels Medical Center Oostkamp | €272,306 | €237,889 | 5.8% | 4.3 |
| EXEL DENTAL Braine-le-Comte | €383,704 | €145,877 | 24.4% | - |
| Orca Consulting Kapellen | €347,741 | €71,787 | 68.8% | - |
| PHARMA 2424 Charleroi | €550,405 | €195,539 | 55.3% | 1.1 |
| DCVISION Kaprijke | €443,302 | €158,650 | 47.6% | - |
These companies have the same main activity as Care4Excellence: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €266,000 and €550,000, founded between 2000 and 2015.
Official details
Source: KBO- Status
- Active since 29-01-2007Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 4 others
- Establishment unit
- 2.159.970.7593090 Overijse, since 19-01-2007
- Financial year end
- 31 December
- Peppol
- Reachable since 21-11-2025
Annual accounts 2025
- €307,250▲ 16.5%
- Filing
- Filed on 22-07-2026, 9 days before the end of the filing period
Insights on Care4Excellence
Care4Excellence files the micro format. That format states no turnover. The gross margin rose from €11,196 in 2009 to €131,173 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Care4Excellence
- What is the company number of Care4Excellence?
- The company number of Care4Excellence is 0886.785.777. The VAT number is the same number with BE in front: BE 0886.785.777.
- Where is Care4Excellence based?
- The registered office is at Akkerplein 7, 3090 Overijse.Company details
- What does Care4Excellence do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
- What is the legal form of Care4Excellence?
- Care4Excellence is a private limited company (BV).
- When was Care4Excellence founded?
- Care4Excellence was founded on 29-01-2007.
- Is Care4Excellence still active?
- Yes, Care4Excellence is an active enterprise in the KBO register.
- What is the turnover of Care4Excellence?
- The turnover in financial year 2025 is ≈ €330,000. This figure is estimated from the gross margin of €131,173 and 2,205 comparable companies of the same size. It probably lies between €220,000 and €510,000. It is a rough estimate.Financials
- Is Care4Excellence profitable?
- In financial year 2025, Care4Excellence made a profit of €85,494.
- Where can I find the annual accounts of Care4Excellence?
- Care4Excellence filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Care4Excellence due?
- Care4Excellence must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.